Please try another search
Shanghai MicroPort Endovascular MedTech Group Co Ltd, formerly Shanghai MicroPort Endovascular MedTech Co Ltd, is a China-based company principally engaged in the research and development, production and sales of aortic and peripheral vascular interventional medical devices. The Company's main products include the aortic stent graft system for aortic minimally invasive interventional procedures, the intraoperative stent system for open surgery, as well as the peripheral vascular stent system and peripheral balloon dilatation catheters for the treatment of peripheral vascular diseases. The Company mainly distributes its products to the domestic market.
Name | Age | Since | Title |
---|---|---|---|
Chengyun Yue | 56 | - | Chairman of the Supervisory Board |
He Li | 47 | - | Supervisor |
Linlin Cai | 41 | - | Employee Representative Supervisor |
Liefeng Qu | 52 | 2018 | Director |
Haibing Wu | 50 | 2018 | Independent Director |
Baolin Liu | 54 | 2018 | Independent Director |
Qing Zhu | 41 | 2018 | GM & Director |
Rong Fu | 58 | 2018 | Independent Director |
Junjie Zhang | 45 | 2018 | Director |
Bo Peng | 54 | 2018 | Independent Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review